Plasma lipidomic profile signature of hypertension in mexican american families: Specific role of diacylglycerols

Hypertension

Volumn 62, Issue 3, 2013, Pages 621-626

  Kulkarni, Hemant ^a   Meikle, Peter J ^b   Mamtani, Manju ^a   Weir, Jacquelyn M ^b   Barlow, Christopher K ^b   Jowett, Jeremy B ^b   Bellis, Claire ^a   Dyer, Thomas D ^a   Johnson, Matthew P ^a   Rainwater, David L ^a   Almasy, Laura ^a   Mahaney, Michael C ^a   Comuzzie, Anthony G ^a   Blangero, John ^a   Curran, Joanne E ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

blood pressure; hypertension; lipid species; lipidomics; Mexican Americans

Indexed keywords

DIACYLGLYCEROL; LIPOPROTEIN;

ARTICLE; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; GENETIC CORRELATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISPANIC; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPIDOMICS; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TANDEM MASS SPECTROMETRY;

BLOOD PRESSURE; HYPERTENSION; LIPID SPECIES; LIPIDOMICS; MEXICAN AMERICANS;

ADULT; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; DIGLYCERIDES; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; MALE; MEXICAN AMERICANS; MIDDLE AGED; TANDEM MASS SPECTROMETRY;

EID: 84883310696     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01396     Document Type: Article

References (48)

1. Jee SH, Jo J. Linkage of epidemiologic evidence with the clinical aspects of metabolic syndrome. . 2012;42:371-378.
2. Zimmerman FH. Cardiovascular disease and risk factors in law enforcement personnel: A comprehensive review. Cardiol Rev. 2012;20:159-166.
3. Knight JA. Diseases and disorders associated with excess body weight. Ann Clin Lab Sci. 2011;41:107-121.
4. McCullough AJ. Epidemiology of the metabolic syndrome in the USA. J Dig Dis. 2011;12:333-340.
5. Bentley-Lewis R, Koruda K, Seely EW. The metabolic syndrome in women. Nat Clin Pract Endocrinol Metab. 2007;3:696-704.
6. Jiang H, Nie L, Li Y, Xie J. Application of ultra-performance liquid chromatography coupled with mass spectrometry to metabonomic study on spontaneously hypertensive rats and intervention effects of Ping Gan prescription. J Sep Sci. 2012;35:483-489.
7. Lawlor DA, Macdonald-Wallis C, Fraser A, Nelson SM, Hingorani A, Davey Smith G, Sattar N, Deanfield J. Cardiovascular biomarkers and vascular function during childhood in the offspring of mothers with hypertensive disorders of pregnancy: Findings from the Avon Longitudinal Study of Parents and Children. Eur Heart J. 2012;33:335-345.
8. Godsland IF, Crook D, Devenport M, Wynn V. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Contraception. 1995;52:143-149.
9. Allemann Y, Horber FF, Colombo M, Ferrari P, Shaw S, Jaeger P, Weidmann P. Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet. 1993;341:327-331.
10. Ferrari P, Weidmann P, Shaw S, Giachino D, Riesen W, Allemann Y, Heynen G. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med. 1991;91:589-596.
11. Akinkugbe OO. Epidemiology of cardiovascular disease in developing countries. J Hypertens Suppl. 1990;8:S233-S238.
12. Ames RP. The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics. Drugs. 1986;32:260-278.
13. Weidmann P, Gerber A, Mordasini R. Effects of antihypertensive therapy on serum lipoproteins. Hypertension. 1983;5:III120-III131.
14. Sironi AM, Gastaldelli A, Mari A, Ciociaro D, Positano V, Postano V, Buzzigoli E, Ghione S, Turchi S, Lombardi M, Ferrannini E. Visceral fat in hypertension: Influence on insulin resistance and beta-cell function. Hypertension. 2004;44:127-133.
15. Ferroni P, Basili S, Paoletti V, Davì G. Endothelial dysfunction and oxidative stress in arterial hypertension. Nutr Metab Cardiovasc Dis. 2006;16:222-233.
16. Wierzbicki AS. Lipid lowering: Another method of reducing blood pressuré J Hum Hypertens. 2002;16:753-760.
17. Graessler J, Schwudke D, Schwarz PE, Herzog R, Shevchenko A, Bornstein SR. Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS One. 2009;4:e6261.
18. Puri R, Duong M, Uno K, Kataoka Y, Nicholls SJ. The emerging role of plasma lipidomics in cardiovascular drug discovery. Expert Opin Drug Discov. 2012;7:63-72.
19. Wei H, Hu C, Wang M, et al. Lipidomics reveals multiple pathway effects of a multi-components preparation on lipid biochemistry in ApoE 3Leiden.CETP mice. PLoS One. 2012;7:e30332.
20. Hu C, Kong H, Qu F, Li Y, Yu Z, Gao P, Peng S, Xu G. Application of plasma lipidomics in studying the response of patients with essential hypertension to antihypertensive drug therapy. Mol Biosyst. 2011;7:3271-3279.
21. Han X, Rozen S, Boyle SH, Hellegers C, Cheng H, Burke JR, Welsh-Bohmer KA, Doraiswamy PM, Kaddurah-Daouk R. Metabolomics in early Alzheimer's disease: Identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One. 2011;6:e21643.
22. Meikle PJ, Christopher MJ. Lipidomics is providing new insight into the metabolic syndrome and its sequelae. Curr Opin Lipidol. 2011;22:210-215.
23. Schuhmann K, Almeida R, Baumert M, Herzog R, Bornstein SR, Shevchenko A. Shotgun lipidomics on a LTQ Orbitrap mass spectrometer by successive switching between acquisition polarity modes. J Mass Spectrom. 2012;47:96-104.
24. Hellmuth C, Weber M, Koletzko B, Peissner W. Nonesterified fatty acid determination for functional lipidomics: Comprehensive ultrahigh performance liquid chromatography-tandem mass spectrometry quantitation, qualification, and parameter prediction. Anal Chem. 2012;84:1483-1490.
25. Kotronen A, Seppänen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepää AL, Yki-Järvinen H, Oresic M. Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Obesity (Silver Spring). 2010;18:937-944.
26. Kotronen A, Velagapudi VR, Yetukuri L, Westerbacka J, Bergholm R, Ekroos K, Makkonen J, Taskinen MR, Oresic M, Yki-Järvinen H. Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia. 2009;52:684-690.
27. Spijkers LJ, van den Akker RF, Janssen BJ, Debets JJ, De Mey JG, Stroes ES, van den Born BJ, Wijesinghe DS, Chalfant CE, MacAleese L, Eijkel GB, Heeren RM, Alewijnse AE, Peters SL. Hypertension is associated with marked alterations in sphingolipid biology: A potential role for ceramide. PLoS One. 2011;6:e21817.
28. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003;52:2160-2167.
29. MacCluer JW, Stern MP, Almasy L, et al. Genetics of atherosclerosis risk factors in Mexican Americans. Nutr Rev. 1999;57(5 Pt 2):S59-S65.
30. Voruganti VS, Lopez-Alvarenga JC, Nath SD, Rainwater DL, Bauer R, Cole SA, Maccluer JW, Blangero J, Comuzzie AG. Genetics of variation in HOMA-IR and cardiovascular risk factors in Mexican-Americans. J Mol Med (Berl). 2008;86:303-311.
31. Kochunov P, Glahn DC, Lancaster J, Winkler A, Karlsgodt K, Olvera RL, Curran JE, Carless MA, Dyer TD, Almasy L, Duggirala R, Fox PT, Blangero J. Blood pressure and cerebral white matter share common genetic factors in Mexican Americans. Hypertension. 2011;57:330-335.
32. Rutherford S, Cai G, Lopez-Alvarenga JC, et al. A chromosome 11q quantitative-trait locus influences change of blood-pressure measurements over time in Mexican Americans of the San Antonio Family Heart Study. Am J Hum Genet. 2007;81:744-755.
33. Rainwater DL, Almasy L, Blangero J, Cole SA, VandeBerg JL, MacCluer JW, Hixson JE. A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles. Arterioscler Thromb Vasc Biol. 1999;19:777-783.
34. Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: The San Antonio Heart Study. Diabetes Care. 2002;25:1177-1184.
35. Murphy RC, James PF, McAnoy AM, Krank J, Duchoslav E, Barkley RM. Detection of the abundance of diacylglycerol and triacylglycerol molecular species in cells using neutral loss mass spectrometry. Anal Biochem. 2007;366:59-70.
36. Smyth I, Hacking DF, Hilton AA, Mukhamedova N, Meikle PJ, Ellis S, Satterley K, Slattery K, Collinge JE, de Graaf CA, Bahlo M, Sviridov D, Kile BT, Hilton DJ. A mouse model of harlequin ichthyosis delineates a key role for Abca12 in lipid homeostasis. PLoS Genet. 2008;4:e1000192.
37. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198-1211.
38. Kullback S, Leibler RA. On information and sufficiency. Ann Math Stat. 1951;22:79-86.
39. Schiffrin EL. Intracellular signal transduction for vasoactive peptides in hypertension. Can J Physiol Pharmacol. 1994;72:954-962.
40. Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 2011;18:139-143.
41. Wang Y, Deng X, Hewavitharana T, Soboloff J, Gill DL. Stim, ORAI and TRPC channels in the control of calcium entry signals in smooth muscle. Clin Exp Pharmacol Physiol. 2008;35:1127-1133.
42. Zulian A, Baryshnikov SG, Linde CI, Hamlyn JM, Ferrari P, Golovina VA. Upregulation of Na+/Ca2+ exchanger and TRPC6 contributes to abnormal Ca2+ homeostasis in arterial smooth muscle cells from Milan hypertensive rats. Am J Physiol Heart Circ Physiol. 2010;299:H624-H633.
43. Jiang XC, Goldberg IJ, Park TS. Sphingolipids and cardiovascular diseases: Lipoprotein metabolism, atherosclerosis and cardiomyopathy. Adv Exp Med Biol. 2011;721:19-39.
44. Anderson SG, Sanders TA, Cruickshank JK. Plasma fatty acid composition as a predictor of arterial stiffness and mortality. Hypertension. 2009;53:839-845.
45. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol. 2003;14:15-19.
46. Zheng ZJ, Folsom AR, Ma J, Arnett DK, McGovern PG, Eckfeldt JH. Plasma fatty acid composition and 6-year incidence of hypertension in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1999;150:492-500.
47. Mazeaud MM, Driss F, Le Quan Sang KH, Duranthon V, Levenson J, Simon A, Devynck MA. Biochemical and functional alterations associated with hypercholesterolemia in platelets from hypertensive patients. Atherosclerosis. 1992;94:201-211.
48. Seidell JC, Cigolini M, Charzewska J, Ellsinger BM, Björntorp P, Hautvast JG, Szostak W. Fat distribution and gender differences in serum lipids in men and women from four European communities. Atherosclerosis. 1991;87:203-210.